León Cachón, R. B. R., Ascacio Martínez, J. Á. I., Gamino Peña, M. E., Cerda Flores, R. M., Meester, I., Gallardo Blanco, H. L., . . . Barrera Saldaña, H. A. (2016). A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers. BMC.
Cita Chicago Style (17a ed.)León Cachón, Rafael B. R., Jorge Ángel Isidro Ascacio Martínez, María E. Gamino Peña, Ricardo Martín Cerda Flores, Irene Meester, Hugo Leonid Gallardo Blanco, Magdalena Gómez Silva, Everardo Piñeyro Garza, y Hugo Alberto Barrera Saldaña. A Pharmacogenetic Pilot Study Reveals MTHFR, DRD3, and MDR1 Polymorphisms as Biomarker Candidates for Slow Atorvastatin Metabolizers. BMC, 2016.
Cita MLA (9a ed.)León Cachón, Rafael B. R., et al. A Pharmacogenetic Pilot Study Reveals MTHFR, DRD3, and MDR1 Polymorphisms as Biomarker Candidates for Slow Atorvastatin Metabolizers. BMC, 2016.